)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Camlin Fine Sciences
Camlin Fine Sciences (CAMLINFINE) investor relations material
Camlin Fine Sciences Q2 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 26/27 earnings summary3 Nov, 2026
Executive summary
Q2 FY27 consolidated revenue rose 9.15% YoY to ₹4,914.65 million, while consolidated net loss widened to ₹297.00 million; continuing-operations PAT was a loss of ₹280.8 million.
Higher input costs, limited pass-through and liquidity constraints pressured margins; Blends and Straights grew while Aroma revenue declined.
Financial highlights
Q2 FY27 revenue was ₹4,914.65 million vs ₹4,502.65 million; H1 revenue was ₹10,113.44 million vs ₹8,579.86 million.
Q2 adjusted EBITDA, excluding FX loss, was ₹22.3 million vs ₹356.3 million YoY; adjusted EBITDA margin was 0.45% vs 7.91%.
H1 adjusted EBITDA was ₹198.8 million vs ₹559.2 million; adjusted EBITDA margin was 1.97% vs 6.52%.
Q2 gross margin was 39.8% vs 46.5%; H1 continuing-operations PAT was a loss of ₹598.8 million vs a loss of ₹50.2 million.
Outlook and guidance
Q3 EBITDA is expected to be at least at Q2 levels with slightly better margins; Q4 turnover guidance is ₹6,000 million and EBITDA above ₹600 million, assuming current input prices.
The earlier FY27 ambition of ₹2,000 crore revenue and ₹200 crore EBITDA is not expected to be achieved.
Vanillin target is at least 1,000 tonnes per quarter from Q4 FY27; Blends growth target is 20%, with over half expected from functional ingredients.
Priorities include improving margins and working-capital cycles, developing functional ingredients and expanding specialty applications and high-value markets.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Camlin Fine Sciences
- Record revenue growth, but margins compressed by high costs and exceptional items.CAMLINFINE
Q1 26/27 - Revenue rose 6% to INR 17,233 million, but margins fell amid costs and discontinued operations.CAMLINFINEQ4 25/26
- FY 2027 targets 4,000 tons vanillin, 25% blends growth, and margin improvement.CAMLINFINEQ3 25/26
- Revenue up 8.6% YoY; vanillin and blends grew, but losses continued amid high costs.CAMLINFINEQ2 25/26
- Revenue and margins dipped, but blends growth, rights issue, and vanillin ramp-up remain on track.CAMLINFINEQ1 25/26
- Q2 FY25 revenue and margins rose, but major impairments drove a significant net loss.CAMLINFINEQ2 24/25
- Q1 FY25 revenue fell 1.5%, but margins improved and Blends grew 13.4% QoQ amid one-time charges.CAMLINFINEQ1 24/25
- 15% revenue growth, margin gains, but net loss widened amid restructuring and acquisitions.CAMLINFINEQ4 24/25
- Revenue and margins rose, but net losses continued amid restructuring and a rights issue.CAMLINFINEQ3 24/25
Next Camlin Fine Sciences earnings date
Q3 26/2712 Feb, 2027
Camlin Fine Sciences
Next Camlin Fine Sciences earnings date
Q3 26/2712 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Camlin Fine Sciences Ltd manufactures and supplies specialty chemicals, including antioxidants and aroma ingredients. Its products are used in food preservation, animal nutrition, pharmaceuticals, and industrial applications. The company is headquartered in Mumbai, India, and its shares are listed on the NSE.